Actinic keratosis – Diagnostics – Overview of Information and Clinical Research

Actinic keratosis, also known as solar keratosis, is a rough and scaly skin condition caused by years of sun exposure that can develop into skin cancer. Understanding how it’s diagnosed and catching it early can make a significant difference in preventing its progression to more serious conditions.

Introduction: Who Should Undergo Diagnostics

Anyone who notices unusual skin changes, particularly on areas frequently exposed to the sun, should consider seeking diagnostic evaluation. Actinic keratosis develops over time through accumulated sun damage, so it’s especially important for certain individuals to remain vigilant about skin examinations.^[1]

You should seek diagnostic evaluation if you notice patches of skin that feel rough or scaly, like sandpaper, especially if they persist or don’t heal. These patches often appear on the scalp, face (particularly the lips, nose, and ears), arms, the back of the hands, or any area that has received significant sun exposure over the years.^[2] The surrounding skin often shows other signs of sun damage, such as wrinkles, freckles, or blotchy discoloration.^[6]

People at higher risk include those who are over 40 years old, have fair skin with a history of sunburn, light-colored hair (red or blonde), and blue or light-colored eyes. Men tend to develop actinic keratoses more frequently than women. If you’ve spent long hours outdoors for work or recreation, live in sunny climates closer to the equator, or have used tanning beds regularly, your risk increases substantially.^[1]^[4]

Those with compromised immune systems, such as organ transplant patients on immunosuppressive medications, face a higher risk of developing actinic keratoses and should be particularly attentive to regular skin monitoring.^[1] Additionally, if you have a personal history of actinic keratosis or skin cancers, regular diagnostic check-ups become even more important.

⚠️ Important

It’s important to seek medical evaluation if a patch on your skin begins to bleed, gets bigger, changes color, feels tender, or develops into a lump. These changes could signal the early development of skin cancer. If you notice a patch appearing on your lips, particularly a white, cracked, or scaly area on the lower lip, this also warrants medical attention.

Many people discover actinic keratoses are more easily felt than seen. You might run your hand over an area of skin and notice it feels unusually rough or textured before you actually see any color change. Some spots may itch, burn, or feel raw and sensitive, particularly under clothing. In rare cases, they may develop persistent sores that don’t heal, or they may come and go in the same spot repeatedly.^[5]

Classic Diagnostic Methods

The diagnosis of actinic keratosis is typically straightforward and can often be made through a simple visual examination. When you visit a primary care physician or a dermatologist (a specialist in skin conditions), they will examine your skin carefully, looking at both the appearance and texture of any concerning areas.^[1]

During the examination, your healthcare provider will look for characteristic features of actinic keratosis. These include rough or scaly patches that may be flat or slightly raised, with colors ranging from skin-colored to pink, red, brown, or gray. The patches are typically less than one inch in diameter, though they can vary in size. Most people don’t have just one spot—multiple actinic keratoses often appear in the same general area of sun-exposed skin.^[2]^[5]

Your doctor may use a special magnifying tool called a dermatoscope to examine your skin more closely. This handheld device allows them to see the skin’s structure in greater detail and can help distinguish actinic keratoses from other skin conditions. The examination is quick and completely painless—the doctor simply places the device against your skin and looks through it.^[1]

Sometimes actinic keratoses can be graded according to their appearance. Grade 1 lesions are mild, appearing as pink or gray marks with slight scaling that feel gritty to touch. Grade 2 lesions are moderate, with thicker buildup of scaly material that’s more easily detected. Grade 3 lesions are severe, with thick, crusty layers of keratin (the protein that makes up the outer layer of skin). Grade 4 indicates confluent areas spanning several centimeters with a range of different severity levels present.^[3]

In cases where the diagnosis is uncertain, or when the provider needs to rule out more serious conditions like squamous cell carcinoma (a type of skin cancer), a skin biopsy may be performed. During this procedure, the doctor will numb the area with a local anesthetic, so you won’t feel pain. They then remove a small sample of the affected skin to send to a laboratory for examination under a microscope.^[1]^[3]

The biopsy can usually be done right in the clinic during your visit. The sample is analyzed by specialists who look at the skin cells’ structure and characteristics to confirm whether the lesion is actinic keratosis or something else. This is particularly important because actinic keratoses can sometimes look similar to other skin conditions, including more serious forms of skin cancer or even benign (non-cancerous) conditions like lentigo maligna.^[14]

The visual examination remains the primary diagnostic tool because experienced healthcare providers can usually recognize actinic keratoses by their distinctive appearance and texture. The rough, sandpaper-like feel combined with the typical coloring and location on sun-exposed areas creates a recognizable pattern that makes diagnosis relatively straightforward in most cases.^[3]

Diagnostics for Clinical Trial Qualification

When patients are being considered for participation in clinical trials investigating new treatments for actinic keratosis, more standardized diagnostic criteria and assessment methods may be used. These ensure that all participants meet specific inclusion criteria and that the trial results can be accurately measured and compared.

Clinical trials typically require confirmed diagnosis of actinic keratosis through visual examination by a qualified dermatologist or healthcare provider. The diagnosis must meet established clinical criteria, including the presence of characteristic rough, scaly patches on sun-exposed skin areas. Researchers may document the number of lesions present, their specific locations on the body, and their severity grades to establish a baseline before any treatment begins.^[3]

In some clinical trial settings, dermoscopy (examination with a magnifying device) may be used systematically to document and characterize lesions more precisely. This allows researchers to track changes in the lesions over time with greater accuracy. Photographic documentation is also commonly employed, with standardized images taken of affected areas before, during, and after treatment to provide visual evidence of any changes.^[3]

Some trials may require histological confirmation through skin biopsy before enrollment, particularly when testing treatments for more advanced or higher-risk actinic keratoses. This ensures that participants truly have the condition being studied and helps exclude individuals who might have other skin conditions that could confound the trial results.^[3]

Patient history is another important component of clinical trial diagnostics. Researchers will document your history of sun exposure, previous actinic keratoses, any past skin cancers, and other risk factors. Information about your immune system status is particularly relevant, as immunosuppressed individuals (such as organ transplant recipients) may have different disease characteristics and treatment responses.^[1]

⚠️ Important

Even after treatment for actinic keratosis, your healthcare provider will likely recommend that you have your skin checked at least once a year for signs of skin cancer. This ongoing monitoring is important because having actinic keratoses indicates sun-damaged skin and puts you at higher risk for developing skin cancers in the future.

Clinical trials may also assess the extent of sun damage across broader areas of skin, not just individual lesions. This concept, sometimes called “field cancerization” or “field change,” recognizes that UV exposure damages larger areas of skin, not just the visible spots. Some newer treatments being tested in clinical trials address these broader areas of sun-damaged skin rather than individual lesions.^[6]

For trial participation, exclusion criteria based on diagnostic findings are also important. For example, if a biopsy reveals that what appeared to be actinic keratosis has already progressed to squamous cell carcinoma, the individual might be excluded from a prevention-focused trial but could be eligible for a different study focused on skin cancer treatment.

Prognosis and Survival Rate

Prognosis

The overall prognosis for people with actinic keratosis is generally very good, especially when lesions are identified early and treated appropriately. Most actinic keratoses can be successfully removed or managed with available treatments. However, the condition does indicate that your skin has sustained significant sun damage, which means you’re at increased risk for developing additional actinic keratoses in the future.^[1]

The primary concern with actinic keratosis is its potential to develop into squamous cell carcinoma, a type of skin cancer. While it’s difficult to predict which individual lesion might progress, the risk is relatively small. Studies suggest that the likelihood of any single actinic keratosis developing into squamous cell carcinoma ranges from about 5% to 10%.^[2]^[3] This progression typically happens slowly over many years when lesions are left untreated.

For patients with multiple actinic keratoses, the cumulative risk increases. Research has found that at approximately four years of follow-up, just under 9% of patients with actinic keratoses developed squamous cell carcinoma. At ten years of follow-up, the incidence increased to about 17%. This demonstrates that while the individual lesion risk is low, having actinic keratoses does indicate an elevated overall risk that increases over time.^[19]

Several factors can influence prognosis. Individuals with compromised immune systems, such as organ transplant recipients taking immunosuppressive medications, face a higher risk of progression to skin cancer. People with many actinic keratoses spread across large areas of skin also have elevated risk. Additionally, if a lesion develops worrisome features—such as becoming thick, hard, growing rapidly, developing into a horn-like shape, or starting to bleed—this may indicate a higher risk of cancer development.^[6]

The good news is that when actinic keratoses are treated, the risk of progression is greatly reduced. Regular monitoring and sun protection can help prevent new lesions from forming and catch any changes early. People diagnosed with actinic keratoses are also at somewhat higher risk for other types of skin cancer, including basal cell carcinoma and melanoma, due to their history of significant sun exposure. This makes ongoing skin surveillance important even after treatment.^[3]

Survival Rate

Actinic keratosis itself is not life-threatening, and there is no survival rate associated with this precancerous condition. The vast majority of actinic keratoses—at least 90%—remain benign, meaning they will not turn into cancer.^[20]

When actinic keratosis does progress to squamous cell carcinoma, the prognosis for that cancer depends on when it’s detected and treated. Most squamous cell carcinomas arising from actinic keratoses are caught early because people are already being monitored for skin changes. Early-stage squamous cell carcinoma, when treated promptly, has excellent cure rates. However, a small subset of squamous cell carcinomas can spread (metastasize) to other parts of the body and become dangerous or even deadly, which is why prevention and early treatment of actinic keratoses is so important.^[19]

The key to the best possible outcome is early detection through regular skin examinations, prompt treatment of identified lesions, and consistent sun protection going forward. Most people with actinic keratosis who receive appropriate treatment and follow-up care continue to live healthy lives without significant complications from this condition.

#1 Clinical Trials Search in Europe